ClinicalTrials.Veeva
Menu
W

Wills Eye Hospital | Neuro

Research site
(Unclaimed)
Location
840 Walnut Street, Philadelphia, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

VRDN 001

Parent organization

This site is a part of Wills Eye Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants with Thyroid Eye Disease (TED) ( THRIVE )

Please note that Phase 1/2 (HV \&amp ; TED MAD) cohorts and Phase 3 component (THRIVE) - recruitment is complete.The investigational drug, ve...

Active, not recruiting
Thyroid Eye Disease
Drug: Veligrotug (VRDN-001) Phase 1/2 MAD (HV and TED)
Drug: VRDN-001 Placebo

Trial sponsors

G
N
V

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems